11 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
2
Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancer.
Yonsei University College of Medicine
60
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.
Epics Therapeutics SA
10
Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors.
Hangzhou Medical College
1
Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors.
The First Hospital of China Medical University
54
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents.
University of Connecticut
5
Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71.
Swansea University
55
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey.
Sapienza University of Rome
